Without causing inflammatory side effects or synapse loss, the researchers think this method could be a breakthrough in the treatment of Alzheimer’s disease. The neurotoxic inflammatory adverse effects of standard treatments are avoided by the novel medication. Based on its capacity to reduce A plaque burden in AD patients, Aduhelm just became the first medication […]
